ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,901 | 69.00195 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 0 | 160,610.125 | 98,081.5625 | null | 41.666657 | white | 31.199219 | 37 | 0.573975 | 0.462952 | 11 | 0 | 0 | no | 0.5 | 0.2 | dnr after sadm | 19 | 96 | 19.699219 | 110 | 10 | 36.59375 | 290 | 2.699707 | 7.699219 | 2 | 151 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
3,902 | 74.31299 | 1 | female | 0 | 15 | 40 | COPD | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 27,789.391 | 19,155.1562 | null | 19 | white | 33 | 56 | 0.460999 | 0.258972 | 11 | 0 | 0 | no | null | null | no dnr | 15 | 72 | 5.799805 | 124 | 31 | 35.5 | 176 | 2.899902 | null | 0.399963 | 138 | 7.459961 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,903 | 66.18994 | 1 | male | 0 | 7 | 89 | Colon Cancer | Cancer | 2 | 10 | under $11k | 0 | 6,248 | 4,065.4219 | null | 6 | black | 27 | 16 | 0.630981 | 0.319946 | 1 | 1 | 0 | metastatic | 0.5 | 0.1 | no dnr | 7 | 101 | 11.798828 | 64 | 16 | 37.39844 | null | 2.5 | null | 0.899902 | 136 | null | null | null | null | 1 | 1 | null | 1 |
3,904 | 58.89697 | 0 | female | 0 | 25 | 1,583 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 91,730.875 | 65,269.1562 | null | 23.5 | white | 18.296875 | 14 | 0.849976 | 0.79895 | 12 | 0 | 0 | no | 0.5 | 0.25 | no dnr | 25 | 72 | 11.199219 | 74 | 8 | 39 | 266.625 | null | null | 0.5 | 135 | 7.459961 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,905 | 65.83398 | 1 | male | 1 | 7 | 7 | Coma | Coma | 1 | 11 | $11-$25k | 44 | 24,014.984 | 16,735.875 | null | 32 | black | 23.796875 | 28 | 0.491943 | 0.419983 | 1 | 0 | 0 | no | 0.25 | 0.2 | dnr after sadm | 5 | 75 | 6.799805 | 11 | 10 | 39.29688 | 386.625 | 3.099609 | 0.599976 | 1.5 | 142 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,906 | 57.487 | 1 | male | 1 | 37 | 37 | MOSF w/Malig | ARF/MOSF | 1 | 11 | under $11k | 0 | 122,004.25 | 77,422.375 | null | 38.25 | white | 18.296875 | 15 | 0.790894 | 0.721924 | 2 | 0 | 0 | yes | 0.8 | 0.5 | dnr after sadm | 24 | 70 | 10 | 100 | 9 | 36.19531 | 226.65625 | null | null | 0.899902 | 139 | 7.419922 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,907 | 70.65295 | 0 | male | 0 | 18 | 1,574 | COPD | COPD/CHF/Cirrhosis | 3 | 5 | null | 0 | 19,755.547 | 13,855.2266 | null | 10 | black | 23 | 32 | 0.79895 | 0.675903 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 18 | 77 | 9.798828 | 72 | 26 | 36.79688 | 225 | 2.399902 | 0.899902 | 1 | 134 | 7.429688 | null | null | null | null | null | no(M2 and SIP pres) | 3.611816 |
3,908 | 53.185 | 1 | male | 0 | 8 | 17 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 41 | 33,711.281 | 21,372.6719 | null | 39.5 | black | 43 | 62 | 0.046997 | 0.014 | 2 | 1 | 0 | yes | 0.7 | 0.5 | no dnr | 8 | 48 | 13 | 52 | 30 | 35.19531 | 104 | 2.099609 | 0.699951 | 2.399902 | 136 | 7.339844 | null | null | null | null | null | <2 mo. follow-up | 2.638184 |
3,909 | 77.63696 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 9,904.242 | 6,551.9062 | null | 11.5 | white | 46 | 67 | 0.195984 | 0.103989 | 1 | 1 | 1 | no | 0.15 | 0.1 | dnr after sadm | 1 | 37 | 26 | 96 | 38 | 35.79688 | 108.32812 | null | null | 1.699951 | 141 | 7.129883 | null | null | null | null | null | <2 mo. follow-up | 4.786133 |
3,910 | 31.59799 | 1 | male | 0 | 11 | 747 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 16 | under $11k | 0 | 156,964.25 | 115,626.062 | null | 15.5 | white | 31.199219 | 51 | 0.744995 | 0.664917 | 38 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 11 | 145 | 4.699219 | 64 | 28 | 36.39844 | 132.5 | 2.099609 | 0.399963 | 5.199219 | 142 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,911 | 59.13998 | 1 | male | 0 | 6 | 164 | Lung Cancer | Cancer | 1 | 17 | >$50k | 0 | 6,011.648 | 3,880.0293 | null | 18 | white | 22.597656 | 12 | 0.598999 | 0.280945 | 1 | 0 | 0 | metastatic | 0.4 | 0 | dnr after sadm | 1 | 87 | 11 | 120 | 24 | 36.29688 | null | null | 0.199982 | 0.599976 | 135 | null | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
3,912 | 47.99698 | 0 | male | 0 | 117 | 1,572 | CHF | COPD/CHF/Cirrhosis | 1 | null | null | 0 | 337,299.25 | 222,272.5 | null | 33.5 | white | 28.296875 | 22 | 0.817993 | 0.704956 | 1 | 0 | 0 | no | null | null | no dnr | 117 | 62 | 14.199219 | 126 | 27 | 38.29688 | 384 | 3 | 1.099854 | 0.799927 | 128 | 7.449219 | null | null | null | null | null | null | 2.044434 |
3,913 | 61.15298 | 1 | male | 0 | 6 | 1,321 | CHF | COPD/CHF/Cirrhosis | 2 | 4 | under $11k | 0 | 6,116.449 | 4,469.4336 | null | 13 | white | 18.699219 | 32 | 0.884888 | 0.807983 | 1 | 1 | 0 | no | 0.5 | 0.3 | no dnr | 6 | 60 | 7.199219 | 62 | 36 | 35.89844 | null | null | null | 1.099854 | 139 | 7.399414 | null | null | null | 2 | null | no(M2 and SIP pres) | 1.839 |
3,914 | 64.07397 | 1 | male | 1 | 14 | 14 | Lung Cancer | Cancer | 1 | 8 | under $11k | 0 | 55,642.438 | 37,272.6562 | null | 30.666656 | black | 42.59375 | 58 | 0.038994 | 0 | 4 | 0 | 0 | metastatic | 0.2 | 0.1 | dnr after sadm | 12 | 73 | 28.699219 | 114 | 27 | 36 | 123.32812 | 3.099609 | 2.5 | 6.199219 | 135 | 7.379883 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,915 | 60.73398 | 0 | male | 0 | 24 | 1,572 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 6 | $11-$25k | 26 | 98,783.438 | 61,616.1562 | null | 31.333328 | white | 26.796875 | 27 | 0.622925 | 0.518921 | 9 | 0 | 0 | no | null | null | no dnr | 24 | 71 | 19.199219 | 114 | 8 | 38.09375 | 155 | 2.899902 | 3 | 1.099854 | 132 | 7.369141 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,916 | 38.27499 | 0 | female | 0 | 145 | 1,572 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 37 | 218,732.875 | 141,284.625 | null | 35.5 | black | 29 | 36 | 0.720947 | 0.635986 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 145 | 147 | 17.597656 | 134 | 12 | 38.5 | 160 | 2.299805 | 1.299805 | 0.599976 | 130 | 7.359375 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.256348 |
3,917 | 43.53998 | 1 | male | 0 | 21 | 38 | Lung Cancer | Cancer | 2 | null | null | 0 | 25,725.641 | 16,881.0312 | null | 14.666664 | black | 25.699219 | 32 | 0.566895 | 0.244995 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 21 | 77 | 6.399414 | 124 | 38 | 39.89844 | 376.1875 | null | 2.399902 | 0.5 | 141 | 7.459961 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,918 | 35.66898 | 0 | female | 0 | 39 | 1,568 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 158,145.75 | 99,069.125 | null | 46.5 | white | 42.398438 | 56 | 0.53894 | 0.424988 | 3 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 39 | 49 | 19.699219 | 144 | 48 | 39.59375 | 55 | 2.799805 | 0.5 | 0.799927 | 135 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,919 | 56.81598 | 1 | female | 1 | 5 | 5 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 12,576.898 | 8,586.6719 | null | 25 | white | 18.199219 | 26 | 0.876953 | 0.795898 | 5 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 5 | 115 | 7.799805 | 72 | 24 | 36.19531 | 300 | null | null | 1.599854 | 133 | 7.449219 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,920 | 42.14099 | 0 | male | 0 | 27 | 1,567 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 88,426.188 | 64,598.4375 | null | 27 | white | 14.898438 | 22 | 0.941895 | 0.901978 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 27 | 59 | 7.399414 | 74 | 24 | 37.79688 | 376.625 | null | 1 | 1.099854 | 132 | 7.469727 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,921 | 47.62198 | 1 | male | 0 | 5 | 288 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 3,364.6 | 2,296.4531 | null | 13 | white | 15.099609 | 12 | 0.866943 | 0.701904 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 5 | 78 | 3.599609 | 64 | 16 | 36.19531 | null | 3.699707 | 1.699951 | 0.799927 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.680176 |
3,922 | 65.20697 | 0 | female | 0 | 7 | 1,566 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 4,139.348 | 3,229.4004 | null | 7 | black | 21.398438 | 48 | 0.844971 | 0.745972 | 1 | 1 | 0 | no | 0.5 | 0.3 | no dnr | 7 | 100 | 5.199219 | 80 | 32 | 36.39844 | 161.875 | 3.399902 | 2.199707 | 1.099854 | 136 | 7.399414 | null | null | null | 4 | 4 | no(M2 and SIP pres) | 4 |
3,923 | 75.07495 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $25-$50k | 0 | 75,079.25 | 47,504.6562 | null | 34.666657 | white | 28.398438 | 54 | 0.633911 | 0.530884 | 5 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 18 | 71 | 15.599609 | 74 | 11 | 37.79688 | 146.65625 | 2.399902 | 3.199707 | 4.099609 | 138 | 7.469727 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,924 | 58.29199 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 100 | 20,454.547 | 13,545.375 | null | 41 | white | 46.195313 | 77 | 0.003 | 0 | 6 | 0 | 0 | no | 0 | 0 | dnr before sadm | -5 | 70 | 15.599609 | 0 | 0 | 35.5 | 228 | null | 0.399963 | 3.5 | 124 | 7.15918 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,925 | 65.86395 | 1 | male | 0 | 17 | 99 | Lung Cancer | Cancer | 1 | null | under $11k | 0 | 15,353.195 | 10,907.9844 | null | 6.666664 | black | 13.898438 | 40 | 0.762939 | 0.511963 | 1 | 0 | 0 | metastatic | 0.6 | 0.1 | dnr after sadm | 2 | 75 | 11 | 88 | 28 | 37.19531 | 228.5625 | 4 | 0.5 | 0.799927 | 130 | 7.489258 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
3,926 | 59.064 | 1 | male | 0 | 5 | 418 | Colon Cancer | Cancer | 1 | 9 | $25-$50k | 0 | 6,036.098 | 3,612.1367 | null | 14 | white | 15.398438 | 9 | 0.846924 | 0.661987 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 5 | 109 | 5.899414 | 80 | 24 | 38.19531 | null | 3.199707 | 0.899902 | 0.899902 | 139 | null | null | null | null | 0 | 0 | null | 0 |
3,927 | 35.57797 | 0 | male | 0 | 13 | 1,557 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 16,707.297 | 10,840.7656 | null | 12.5 | black | 28.5 | 27 | 0.900879 | 0.832886 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 13 | 70 | 9.798828 | 120 | 30 | 36 | 295.625 | 2.699707 | null | 0.899902 | 133 | 7.349609 | null | null | null | 0 | 5 | no(M2 and SIP pres) | 5 |
3,928 | 25.56899 | 0 | male | 0 | 22 | 1,558 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 15 | under $11k | 9 | 36,389.594 | 25,027.0312 | null | 18.333328 | white | 35.898438 | 57 | 0.674927 | 0.579956 | 9 | 1 | 0 | no | null | null | no dnr | 22 | 119 | 1.299805 | 114 | 12 | 35.79688 | 456.625 | 2.199707 | 0.899902 | 5.299805 | 144 | 7.439453 | null | null | null | 2 | null | null | 1.839 |
3,929 | 60.05197 | 1 | male | 0 | 4 | 287 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 16 | null | 0 | 4,399.648 | 2,730.6269 | null | 7 | white | 19.796875 | 23 | 0.792969 | 0.667969 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 4 | 71 | 6.299805 | 72 | 16 | 36.69531 | null | null | 7.299805 | 1 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.868897 |
3,930 | 88.19196 | 1 | male | 0 | 17 | 711 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 37 | 29,291.234 | 19,606.7969 | null | 21.666656 | black | 27.898438 | 65 | 0.45697 | 0.337952 | 1 | 0 | 1 | no | 0.8 | 0.6 | dnr after sadm | 2 | 52 | 7.299805 | 144 | 11 | 36.69531 | 240 | 2.099609 | 0.399963 | 2.299805 | 139 | 7.269531 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
3,931 | 48.42999 | 1 | male | 1 | 6 | 6 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 10 | $11-$25k | 61 | 22,941.047 | 15,236.8125 | null | 40 | white | 37.296875 | 55 | 0.197998 | 0.059998 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 75 | 12.898438 | 138 | 10 | 34.79688 | 98.32812 | 2.199707 | 2.399902 | 1.899902 | 138 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,932 | 72.78894 | 1 | male | 0 | 4 | 179 | Lung Cancer | Cancer | 2 | 14 | >$50k | 0 | 3,910.1 | 2,377.082 | null | 6 | white | 25.5 | 36 | 0.47699 | 0.159973 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 4 | 120 | 11.398438 | 120 | 28 | 36.09375 | null | null | 0.599976 | 1.799805 | 136 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,933 | 25.618 | 1 | female | 1 | 12 | 12 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 37 | 47,193.688 | 30,280.5 | null | 46 | black | 41 | 83 | 0.458984 | 0.256958 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 10 | 59 | 15.699219 | 100 | 33 | 35.59375 | 213.3125 | 2.299805 | 20.296875 | 3.299805 | 130 | 7.439453 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,934 | 50.11398 | 0 | male | 0 | 6 | 1,551 | CHF | COPD/CHF/Cirrhosis | 2 | null | under $11k | 0 | 8,178.348 | 5,508.793 | null | 21 | black | 17.597656 | 16 | 0.915894 | 0.856934 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 115 | 5.799805 | 100 | 28 | 36.69531 | 304.75 | null | null | 0.899902 | 141 | 7.419922 | null | null | null | 0 | null | null | 0.4948 |
3,935 | 59.28497 | 1 | male | 1 | 17 | 17 | Lung Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 42,512.125 | 27,666.9688 | null | 32.666657 | white | 35.398438 | 23 | 0.233978 | 0.028 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 8 | 103 | 20.199219 | 100 | 20 | 37 | 290.4375 | 2.099609 | 0.199982 | 0.5 | 138 | 7.5 | null | null | null | 4 | 6 | <2 mo. follow-up | 6 |
3,936 | 50.396 | 1 | female | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 1 | 10 | $11-$25k | 0 | 134,989.125 | 83,926.1875 | null | 33.333313 | white | 25.097656 | 28 | 0.587891 | 0.478943 | 42 | 0 | 0 | yes | 0.7 | 0.4 | dnr after sadm | 14 | 109 | 39.195313 | 106 | 28 | 36.59375 | 160 | 2.699707 | null | 1.099854 | 137 | 7.479492 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,937 | 69.72498 | 1 | female | 1 | 56 | 56 | COPD | COPD/CHF/Cirrhosis | 1 | 11 | under $11k | 0 | 303,683.5 | 192,640.75 | null | 43.25 | white | 34.695313 | 36 | 0.460999 | 0.258972 | 14 | 0 | 0 | no | 0 | 0 | dnr after sadm | 46 | 113 | 12.599609 | 120 | 36 | 38 | 193.3125 | 2.599609 | 1.5 | 0.799927 | 148 | 7.349609 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,938 | 47.10999 | 1 | female | 0 | 7 | 532 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 6,076.496 | 4,425.5273 | null | 6 | black | 20.296875 | 29 | 0.849976 | 0.75293 | 1 | 0 | 1 | no | 0.7 | 0.5 | no dnr | 7 | 80 | 10.398438 | 100 | 20 | 38 | null | 1.599854 | 5.799805 | 0.899902 | 136 | null | null | null | null | 0 | 1 | null | 1 |
3,939 | 77.96899 | 1 | female | 1 | 19 | 19 | COPD | COPD/CHF/Cirrhosis | 1 | null | under $11k | 26 | 63,867.688 | 43,432.9062 | null | 36 | white | 35.195313 | 40 | 0.32196 | 0.138977 | 1 | 0 | 0 | no | 0.05 | 0.000125 | dnr after sadm | 16 | 103 | 12.199219 | 96 | 36 | 36.09375 | 260 | 2.5 | 5.299805 | 0.699951 | 129 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,940 | 43.99698 | 1 | male | 1 | 19 | 19 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 14 | null | 9 | 42,310.281 | 27,209.7812 | null | 18.666656 | hispanic | 21.398438 | 20 | 0.830933 | 0.723999 | 1 | 0 | 0 | no | null | null | no dnr | 19 | 97 | 8.199219 | 130 | 12 | 38.79688 | 496.625 | null | 1.799805 | 0.799927 | 142 | 7.5 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,941 | 19.85199 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 95,530.875 | 59,617.7812 | null | 49.5 | white | 43.5 | 65 | 0.56897 | 0.457947 | 8 | 0 | 0 | no | 0.01 | 0.000001 | no dnr | 8 | 63 | 20.097656 | 124 | 20 | 38.39844 | 98.32812 | 3.199707 | 21.199219 | 3.699707 | 137 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 1.882568 |
3,942 | 79.69098 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 37 | 172,505.125 | 110,413.75 | null | 39.666657 | white | 28.898438 | 56 | 0.367981 | 0.25 | 17 | 0 | 0 | no | null | null | dnr after sadm | 17 | 56 | 9.599609 | 114 | 34 | 38.5 | 293.3125 | 4.099609 | 9.5 | 0.799927 | 136 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,943 | 40.34998 | 0 | female | 0 | 19 | 1,546 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | under $11k | 0 | 34,898.594 | 22,762.2812 | null | 10 | black | 32.796875 | 42 | 0.724976 | 0.640991 | 4 | 0 | 0 | no | null | null | no dnr | 19 | 87 | 13.699219 | 80 | 20 | 35.59375 | 125 | 2.799805 | 0.299988 | 8.398438 | 127 | 7.40918 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,944 | 36.90298 | 1 | male | 0 | 16 | 53 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | >$50k | 0 | 25,755.594 | 17,364.1406 | null | 24.333328 | hispanic | 39.09375 | 73 | 0.631958 | 0.528931 | 2 | 0 | 0 | no | null | null | no dnr | 16 | 73 | 12.298828 | 130 | 9 | 34.89844 | 347.5625 | 2.399902 | 5.5 | 2.599609 | 131 | 7.40918 | null | null | null | 5 | 6 | <2 mo. follow-up | 6 |
3,945 | 76.51196 | 1 | female | 0 | 9 | 331 | Lung Cancer | Cancer | 1 | 8 | null | 0 | 6,821.75 | 4,828.9609 | null | 8 | white | 14.5 | 25 | 0.72998 | 0.457947 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 9 | 109 | 1.299805 | 92 | 20 | 36.79688 | null | null | null | 1.099854 | 139 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
3,946 | 41.629 | 1 | male | 0 | 38 | 1,238 | Coma | Coma | 0 | 8 | $11-$25k | 61 | 64,012.688 | 42,502.8438 | null | 22.25 | white | 26.199219 | 46 | 0.574951 | 0.508911 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 38 | 114 | 13.798828 | 114 | 60 | 40 | 227.5 | null | 1.199951 | 1.399902 | 144 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,947 | 40.452 | 0 | male | 0 | 12 | 1,545 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | null | 44 | 31,204.594 | 20,957.7812 | null | 20 | black | 21.796875 | 14 | 0.779907 | 0.708984 | 4 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 12 | 117 | 16.097656 | 98 | 26 | 36.09375 | 260 | null | null | 0.799927 | 135 | 7.339844 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,948 | 71.96698 | 1 | female | 1 | 19 | 19 | Coma | Coma | 0 | 12 | $25-$50k | 61 | 50,624.125 | 33,906.875 | null | 34.666657 | white | 25.597656 | 51 | 0.286987 | 0.217987 | 1 | 0 | 0 | no | 0.2 | 0.1 | dnr after sadm | 10 | 137 | 15.5 | 116 | 35 | 38.5 | 372 | 2.799805 | null | 2.099609 | 134 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,949 | 43.37299 | 1 | male | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 1 | 15 | $25-$50k | 100 | 21,115.188 | 12,553.6641 | null | 44 | black | 81.796875 | 84 | 0 | 0 | 5 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 3 | 0 | 16.898438 | 0 | 14 | 35.79688 | 273.3125 | 2.599609 | 12.599609 | 4.299805 | 149 | 7.319336 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,950 | 56.556 | 1 | female | 0 | 6 | 283 | Colon Cancer | Cancer | 1 | 12 | $25-$50k | 0 | 6,480.297 | 4,016.7168 | null | 10 | white | 24.796875 | 16 | 0.705933 | 0.421997 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 6 | 103 | 6 | 100 | 28 | 38.5 | null | 2.899902 | 1.199951 | 0.599976 | 140 | null | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
3,951 | 82.58197 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 26 | 63,105.875 | 39,187.0312 | null | 31.5 | white | 48.5 | 62 | 0.018997 | 0.004 | 6 | 0 | 0 | no | 0 | 0 | dnr after sadm | 7 | 47 | 17 | 106 | 10 | 36.09375 | 260 | null | 10 | 6.099609 | 123 | 7.319336 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,952 | 36.74197 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 0 | 12 | null | 0 | 36,980.094 | 24,034.9375 | null | 37 | black | 30.199219 | 42 | 0.517944 | 0.40094 | 8 | 0 | 0 | yes | 0.5 | 0.1 | dnr after sadm | 8 | 63 | 14.5 | 140 | 32 | 35.69531 | 146.65625 | null | null | 1.099854 | 143 | 7.469727 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,953 | 48.30698 | 0 | male | 0 | 17 | 1,540 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 33,070.469 | 20,807.9219 | null | 12.333328 | white | 27.699219 | 32 | 0.797974 | 0.730957 | 2 | 0 | 0 | no | 1 | 1 | no dnr | 17 | 110 | 28.199219 | 50 | 16 | 37 | 443.4375 | 2.799805 | null | 5 | 131 | 7.40918 | null | null | null | null | null | null | 2.640137 |
3,954 | 65.13599 | 1 | male | 0 | 15 | 1,178 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $25-$50k | 0 | 57,069.969 | 36,112.25 | null | 31.333328 | white | 38.195313 | 67 | 0.421997 | 0.302979 | 1 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 15 | 53 | 20 | 116 | 28 | 39 | 194 | 3.299805 | 4.799805 | 2.199707 | 130 | 7.439453 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,955 | 48.931 | 0 | male | 0 | 37 | 1,538 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | >$50k | 0 | 79,986.812 | 54,028.7812 | null | 27 | black | 14.199219 | 10 | 0.910889 | 0.878906 | 9 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 37 | 111 | 13.798828 | 74 | 8 | 38.89844 | 304 | 3.199707 | 0.299988 | 1 | 138 | 7.369141 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
3,956 | 73.54999 | 1 | male | 1 | 40 | 40 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 154,653.25 | 101,745.938 | null | 38.5 | white | 34.898438 | 85 | 0.540894 | 0.426941 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 40 | 136 | 14.599609 | 158 | 29 | 35.59375 | 200 | 1.599854 | 3.299805 | 5.5 | 138 | 7.519531 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,957 | 77.86694 | 0 | male | 0 | 192 | 1,537 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 16 | $11-$25k | 9 | 492,828 | 334,111.75 | null | 38.75 | white | 28.398438 | 47 | 0.542969 | 0.428955 | 14 | 1 | 0 | no | 0.6 | 0.6 | dnr after sadm | 82 | 75 | 21.597656 | 140 | 9 | 38.29688 | 187.5 | null | null | 2.199707 | 151 | 7.389648 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.616211 |
3,958 | 67.54297 | 1 | female | 1 | 11 | 11 | COPD | COPD/CHF/Cirrhosis | 3 | 13 | under $11k | 0 | 7,606.227 | 5,431.7109 | null | 11 | white | 23 | 25 | 0.815918 | 0.701904 | 1 | 0 | 0 | no | 0.3 | 0.15 | dnr after sadm | 1 | 80 | 3.699707 | 106 | 24 | 37.39844 | 164 | null | 0.299988 | 0.399963 | 136 | 7.25 | null | null | null | 5 | 5 | <2 mo. follow-up | 5 |
3,959 | 76.61597 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 7 | under $11k | 44 | 54,942.594 | 35,570.4375 | null | 30.5 | white | 20.796875 | 21 | 0.630981 | 0.527954 | 4 | 0 | 0 | no | null | null | dnr after sadm | 1 | 81 | 13.898438 | 64 | 40 | 39.79688 | 410 | 3.099609 | 0.899902 | 0.799927 | 146 | 7.469727 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,960 | 56.91998 | 1 | male | 1 | 8 | 8 | Coma | Coma | 1 | 16 | >$50k | 100 | 39,522.688 | 27,228.875 | null | 29.5 | white | 22.296875 | 23 | 0.085999 | 0.049995 | 16 | 0 | 0 | metastatic | 0.6 | 0.3 | dnr after sadm | 2 | 111 | 12.199219 | 116 | 22 | 36.59375 | 316.625 | 1.799805 | 0.699951 | 0.5 | 135 | 7.429688 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,961 | 42.46997 | 0 | male | 0 | 11 | 1,534 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 9 | 22,030.047 | 15,530.1797 | null | 14 | white | 15.199219 | 12 | 0.919922 | 0.890991 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 11 | 101 | 5.799805 | 70 | 12 | 38.09375 | 304.75 | null | 0.199982 | 0.699951 | 136 | 7.439453 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
3,962 | 34.56299 | 1 | male | 0 | 5 | 427 | Lung Cancer | Cancer | 1 | null | null | 0 | 6,135.598 | 3,612.6094 | null | 12 | white | 15 | 7 | 0.803955 | 0.582886 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 87 | 11.898438 | 84 | 20 | 36.09375 | 266.625 | 3.699707 | 0.5 | 0.699951 | 140 | 7.469727 | null | null | null | null | null | null | 1.915527 |
3,963 | 79.19196 | 1 | male | 0 | 44 | 390 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | >$50k | 0 | 99,666.938 | 66,717.125 | null | 24.25 | white | 33.695313 | 48 | 0.492981 | 0.375977 | 3 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 44 | 52 | 16.296875 | 74 | 26 | 37.59375 | 179.5625 | 2.5 | null | 4.299805 | 130 | 7.359375 | null | null | null | null | 0 | SIP>=30 | 0 |
3,964 | 80.60498 | 1 | male | 0 | 36 | 193 | COPD | COPD/CHF/Cirrhosis | 3 | 24 | $25-$50k | 0 | 36,915.625 | 25,450.3594 | null | 10.5 | white | 22.898438 | 29 | 0.646973 | 0.467957 | 2 | 0 | 0 | yes | null | null | no dnr | 36 | 87 | 15.599609 | 64 | 28 | 36.59375 | 145.6875 | null | 0.299988 | 1 | 134 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,965 | 44.39398 | 1 | male | 1 | 3 | 3 | Coma | Coma | 0 | null | null | 100 | 11,347.344 | 7,430.0469 | null | 25 | black | 80 | 73 | 0 | 0 | 1 | 0 | 0 | no | 0 | 0 | dnr after sadm | 3 | 0 | 20.796875 | 0 | 0 | 35 | 544 | null | null | 2.5 | 154 | 7.479492 | null | null | null | null | null | <2 mo. follow-up | 1.374268 |
3,966 | 51.504 | 1 | male | 0 | 171 | 259 | Coma | Coma | 0 | null | null | 94 | 156,180.375 | 108,716.25 | null | 27.25 | black | 14.599609 | 11 | 0.630981 | 0.569946 | 1 | 0 | 0 | no | 0.4 | 0.1 | dnr after sadm | 36 | 81 | 7.5 | 66 | 26 | 38.29688 | 303.3125 | 2.899902 | null | 1.199951 | 145 | 7.439453 | null | null | null | null | null | null | 2.008789 |
3,967 | 75.35699 | 1 | male | 1 | 62 | 62 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 9 | under $11k | 0 | 169,118.25 | 111,419.812 | null | 31.5 | black | 29.5 | 59 | 0.560913 | 0.448975 | 21 | 1 | 0 | no | null | null | dnr after sadm | 59 | 65 | 0.199982 | 110 | 8 | 36.79688 | 233.3125 | 2.399902 | null | 0.599976 | 134 | 7.5 | null | null | null | null | 7 | null | 7 |
3,968 | 67.52399 | 0 | male | 0 | 44 | 1,529 | Coma | Coma | 1 | 8 | null | 37 | 141,597.75 | 92,144.4375 | null | 34.5 | black | 20.699219 | 52 | 0.506958 | 0.435974 | 8 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 44 | 75 | 8.398438 | 156 | 37 | 38.5 | 305.6875 | 2.399902 | 0.399963 | 1.5 | 138 | 7.40918 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,969 | 48.728 | 1 | male | 0 | 10 | 849 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,446.398 | 7,117.5312 | null | 8.5 | black | 22.699219 | 33 | 0.878906 | 0.797974 | 1 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 10 | 106 | 5.699219 | 84 | 20 | 35.79688 | null | 3.099609 | 2.199707 | 1.699951 | 134 | null | null | null | null | 0 | null | null | 0.4948 |
3,970 | 66.80597 | 1 | male | 0 | 8 | 320 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 7,554.199 | 5,042.9414 | null | 8 | white | 31.796875 | 17 | 0.311951 | 0.056 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 8 | 100 | 14.798828 | 100 | 24 | 36.59375 | 420 | 2.299805 | 1.299805 | 1 | 144 | 7.389648 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,971 | 68.70898 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $11-$25k | 0 | 94,199.812 | 59,171.6875 | null | 38 | white | 29.097656 | 36 | 0.705933 | 0.616943 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 19 | 115 | 12.798828 | 124 | 33 | 37.19531 | 108.32812 | null | 0.799927 | 0.899902 | 140 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,972 | 40.99899 | 1 | male | 0 | 14 | 444 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | null | 0 | 13,750.117 | 9,702.7188 | null | 9 | black | 29.796875 | 36 | 0.823975 | 0.713989 | 1 | 0 | 0 | no | null | null | no dnr | 14 | 120 | 5.299805 | 85 | 22 | 36 | 300 | 2.099609 | 0.399963 | 3.299805 | 142 | 7.449219 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,973 | 52.97198 | 1 | male | 1 | 8 | 8 | Coma | Coma | 0 | 11 | null | 100 | 18,601.594 | 12,105.8828 | null | 20.5 | black | 17.898438 | 6 | 0.505981 | 0.434998 | 1 | 0 | 0 | no | 0.02 | 0.000008 | no dnr | 8 | 96 | 17.199219 | 52 | 12 | 36.69531 | 290 | null | 0.299988 | 1.099854 | 136 | 7.5 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
3,974 | 66.64496 | 0 | female | 0 | 78 | 1,527 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 269,475.5 | 176,331.75 | null | 42.75 | black | 40.09375 | 76 | 0.199982 | 0.106995 | 13 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 78 | 51 | 20 | 104 | 38 | 38.79688 | 208 | 3.799805 | 12.099609 | 2.099609 | 131 | 7.399414 | null | null | null | null | null | null | 2.439453 |
3,975 | 62.69998 | 0 | male | 0 | 14 | 1,526 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $11-$25k | 26 | 55,241.594 | 36,863.125 | null | 14 | white | 24.898438 | 19 | 0.665894 | 0.56897 | 7 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 14 | 100 | 16.296875 | 124 | 14 | 36 | 255.53125 | null | null | 0.699951 | 147 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,976 | 49.45099 | 1 | female | 0 | 23 | 297 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 9 | 92,412.438 | 56,558.4062 | null | 36 | white | 19.597656 | 28 | 0.852905 | 0.802979 | 6 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 23 | 133 | 8 | 64 | 12 | 37.39844 | 292 | null | null | 0.399963 | 132 | 7.469727 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,977 | 61.99298 | 1 | female | 1 | 13 | 13 | MOSF w/Malig | ARF/MOSF | 2 | 7 | under $11k | 0 | 58,915.594 | 38,120.125 | null | 49.5 | white | 35.695313 | 50 | 0.399963 | 0.279968 | 1 | 0 | 0 | yes | null | null | dnr after sadm | 13 | 50 | 25.296875 | 110 | 20 | 36.59375 | 54 | 2.399902 | 0.099991 | 1.099854 | 139 | 7.349609 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
3,978 | 39.82999 | 0 | female | 0 | 9 | 1,525 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | under $11k | 0 | 28,210.188 | 19,233.4688 | null | 22 | black | 22.296875 | 43 | 0.891968 | 0.852905 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 142 | 6.399414 | 114 | 28 | 38.29688 | 160 | 2.599609 | 0.5 | 1.199951 | 137 | 7.479492 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,979 | 41.91898 | 0 | male | 0 | 5 | 1,524 | Colon Cancer | Cancer | 1 | null | null | 0 | 4,684.547 | 2,984.4473 | null | 14 | black | 21.097656 | 14 | 0.803955 | 0.582886 | 1 | 0 | 0 | metastatic | null | null | no dnr | 5 | 73 | 5.699219 | 104 | 24 | 38.29688 | null | 2.899902 | 0.199982 | 1.199951 | 139 | null | null | null | null | null | null | null | 1.804199 |
3,980 | 70.52197 | 1 | male | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 100 | 93,077.688 | 60,741.5312 | null | 32.333313 | white | 28.199219 | 30 | 0.188995 | 0.098999 | 4 | 0 | 0 | no | 0.3 | 0.15 | dnr after sadm | 19 | 65 | 14.599609 | 118 | 23 | 36.79688 | 157.5 | null | 2.599609 | 1.099854 | 152 | 7.509766 | null | null | null | null | null | <2 mo. follow-up | 3.044922 |
3,981 | 59.95099 | 1 | male | 0 | 9 | 493 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 6 | under $11k | 9 | 37,907.438 | 24,762.9375 | null | 27.5 | white | 29.199219 | 40 | 0.694946 | 0.603882 | 2 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 9 | 109 | 9.298828 | 126 | 32 | 35.39844 | 168.5625 | null | null | 1.599854 | 138 | 7.469727 | null | null | null | 5 | 7 | SIP>=30 | 7 |
3,982 | 63.064 | 0 | female | 0 | 23 | 1,522 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 70,353 | 45,316.9688 | null | 31.333328 | white | 27.097656 | 35 | 0.738892 | 0.656982 | 3 | 1 | 0 | no | 0.8 | 0.75 | no dnr | 23 | 67 | 11.398438 | 120 | 17 | 37.79688 | 141.65625 | 2.5 | 0.599976 | 1.199951 | 156 | 7.419922 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,983 | 52.70898 | 1 | female | 0 | 9 | 29 | Lung Cancer | Cancer | 1 | 10 | under $11k | 0 | 13,646.242 | 9,036.8516 | null | 20.5 | white | 30.597656 | 24 | 0.394958 | 0.099991 | 1 | 0 | 0 | metastatic | 0.8 | 0.6 | no dnr | 9 | 77 | 7.199219 | 124 | 24 | 38.59375 | 292 | 2.399902 | 0.399963 | 0.699951 | 140 | 7.389648 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
3,984 | 31.28299 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 12 | null | 44 | 52,990.125 | 34,947.8438 | null | 40 | white | 35.296875 | 63 | 0.591919 | 0.483948 | 1 | 0 | 0 | no | 0.6 | 0.5 | dnr after sadm | 6 | 105 | 19.398438 | 124 | 30 | 38.19531 | 303.3125 | 2.599609 | 20 | 2.5 | 145 | 7.489258 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
3,985 | 57.21597 | 0 | female | 0 | 53 | 1,521 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | null | 0 | 173,402.5 | 116,365.75 | null | 37 | white | 30 | 44 | 0.740967 | 0.659912 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 53 | 129 | 8.199219 | 124 | 10 | 38.39844 | 146 | 2.599609 | 0.799927 | 5 | 131 | 7.359375 | null | null | null | null | 1 | null | 1 |
3,986 | 53.33298 | 1 | male | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 57,244.219 | 36,879.25 | null | 33 | white | 28.597656 | 26 | 0.745972 | 0.665894 | 4 | 0 | 0 | no | 0.3 | 0.2 | no dnr | 10 | 70 | 6 | 130 | 18 | 38.29688 | 93.32812 | null | null | 0.799927 | 135 | 7.389648 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
3,987 | 56.04898 | 1 | male | 0 | 38 | 742 | MOSF w/Malig | ARF/MOSF | 1 | null | under $11k | 0 | 67,626.438 | 44,162.25 | null | 26 | white | 34.398438 | 52 | 0.420959 | 0.301941 | 2 | 0 | 0 | yes | null | null | no dnr | 38 | 95 | 0.799927 | 136 | 9 | 38.29688 | 185 | null | null | 2.599609 | 144 | 7.299805 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,988 | 54.92099 | 0 | male | 0 | 148 | 1,518 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 7 | null | 37 | 244,624.625 | 159,445.375 | null | 26.5 | white | 31.199219 | 87 | 0.582886 | 0.473999 | 1 | 0 | 0 | no | null | null | no dnr | 148 | 77 | 11 | 70 | 38 | 36.09375 | 312 | 1.799805 | 9.599609 | 9.199219 | 132 | 7.399414 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,989 | 59.29898 | 1 | male | 0 | 14 | 67 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 16,175.344 | 10,839.3125 | null | 13.5 | white | 14.699219 | 9 | 0.761963 | 0.510986 | 1 | 0 | 0 | metastatic | 1 | 0.8 | no dnr | 14 | 95 | 10.798828 | 76 | 16 | 36.89844 | null | null | 0.5 | 0.799927 | 138 | null | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
3,990 | 53.03198 | 0 | male | 0 | 261 | 1,517 | CHF | COPD/CHF/Cirrhosis | 2 | 10 | $11-$25k | 0 | null | null | null | 20.5 | white | 21 | 21 | 0.882935 | 0.804932 | 1 | 0 | 0 | no | null | null | no dnr | 261 | 67 | 7.899414 | 112 | 15 | 35.59375 | 428.5625 | null | 0.799927 | 1.099854 | 134 | 7.509766 | null | null | null | 3 | 3 | no(M2 and SIP pres) | 3 |
3,991 | 61.55499 | 1 | male | 0 | 15 | 770 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | $25-$50k | 0 | 35,619.375 | 21,743.2031 | null | 23.666656 | white | 25.296875 | 53 | 0.800903 | 0.734985 | 1 | 0 | 0 | no | null | null | no dnr | 15 | 172 | 6.5 | 136 | 47 | 35.59375 | 233.3125 | 1.899902 | 0.399963 | 1.399902 | 141 | 7.339844 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
3,992 | 77.659 | 1 | male | 1 | 12 | 12 | CHF | COPD/CHF/Cirrhosis | 2 | 8 | $11-$25k | 0 | 37,074.156 | 21,822.0469 | null | 31 | white | 32.59375 | 42 | 0.578979 | 0.384949 | 1 | 0 | 0 | no | null | null | dnr after sadm | 2 | 63 | 7.199219 | 106 | 15 | 35.69531 | 167.5 | null | null | 2.699707 | 128 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
3,993 | 68.18597 | 1 | male | 0 | 29 | 99 | Lung Cancer | Cancer | 2 | 13 | $25-$50k | 0 | 32,881.094 | 22,047.1562 | null | 10.5 | white | 15.599609 | 11 | 0.726929 | 0.453979 | 1 | 0 | 0 | metastatic | 0.5 | 0.3 | no dnr | 29 | 83 | 13.099609 | 80 | 20 | 37.5 | null | null | 0.199982 | 0.699951 | 134 | null | null | null | null | 3 | 2 | adl>=4 (>=5 if sur) | 2 |
3,994 | 63.83298 | 1 | male | 0 | 6 | 930 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 5,728.848 | 3,659.584 | null | 8 | white | 18.097656 | 9 | 0.804932 | 0.582886 | 1 | 0 | 0 | metastatic | 0.9 | 0.7 | no dnr | 6 | 99 | 4.5 | 76 | 22 | 36.69531 | null | 3.099609 | null | 1 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
3,995 | 43.58698 | 1 | female | 0 | 35 | 362 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 116,817.688 | 74,611 | null | 28.25 | white | 30.296875 | 39 | 0.583984 | 0.473999 | 19 | 0 | 0 | metastatic | 0.85 | 0.8 | no dnr | 35 | 114 | 15.898438 | 134 | 10 | 38.5 | 140 | 2.799805 | 5.5 | 0.799927 | 142 | 7.459961 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
3,996 | 89.23199 | 1 | male | 0 | 18 | 201 | COPD | COPD/CHF/Cirrhosis | 3 | 4 | under $11k | 0 | 33,702.719 | 21,365.2656 | null | 25 | black | 29.097656 | 49 | 0.494995 | 0.293945 | 1 | 0 | 0 | no | 0.05 | 0.000125 | no dnr | 18 | 63 | 5.699219 | 130 | 6 | 37 | 117.76562 | null | null | 1.799805 | 146 | 7.489258 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
3,997 | 69.98499 | 1 | female | 0 | 8 | 87 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 7,079.297 | 5,065.1289 | null | 6 | white | 30.199219 | 27 | 0.535889 | 0.212982 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | no dnr | 8 | 122 | 31.097656 | 76 | 28 | 35.79688 | null | 2.699707 | 0.099991 | 0.599976 | 137 | 7.479492 | null | null | null | 2 | 0 | adl>=4 (>=5 if sur) | 0 |
3,998 | 65.62396 | 1 | male | 0 | 13 | 64 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 3 | null | 0 | 43,053.844 | 26,501.4375 | null | 20.5 | black | 21.199219 | 18 | 0.682983 | 0.588989 | 13 | 0 | 0 | metastatic | 0.8 | 0.8 | dnr after sadm | 8 | 75 | 10 | 130 | 24 | 36.5 | null | null | null | 0.799927 | 139 | null | null | null | null | null | 3 | null | 3 |
3,999 | 23.19199 | 1 | male | 0 | 11 | 82 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 24,461.188 | 16,495.3906 | null | 27.5 | black | 27.199219 | 34 | 0.883911 | 0.842896 | 1 | 0 | 0 | no | 0.99 | 0.98 | no dnr | 11 | 122 | 15.199219 | 114 | 41 | 37.69531 | 220 | null | null | 0.199982 | 136 | 7.589844 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
4,000 | 60.646 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 61 | 79,154.938 | 46,919.625 | null | 53 | white | 37.195313 | 48 | 0.152985 | 0.07399 | 13 | 0 | 0 | no | null | null | dnr after sadm | 4 | 61 | 16.597656 | 124 | 8 | 36 | 160 | 2.5 | 3.099609 | 5.399414 | 131 | 7.369141 | null | null | null | null | null | <2 mo. follow-up | 3.036621 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.